DarioHealth Corp (NAS:DRIO)
$ 0.92 -0.0502 (-5.17%) Market Cap: 28.82 Mil Enterprise Value: 36.51 Mil PE Ratio: 0 PB Ratio: 0.41 GF Score: 62/100

DarioHealth Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2021 / 02:40PM GMT
Release Date Price: $18.56 (-1.90%)
Adam Evan Heussner;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. Let's go ahead and get started. Hello, everyone. My name is Adam Heussner, part of the Health Care Technology and Distribution team here at Credit Suisse. Thanks for joining us today. Next up, we have Erez Raphael, CEO; and Rick Anderson, President of North America from DarioHealth. By way of background, DarioHealth offers a comprehensive digital therapeutics platform covering multiple chronic conditions, including diabetes, hypertension, weight management, musculoskeletal and behavioral health, all within one integrated technology platform. We've got some prepared questions, but if anyone from the audience wants to ask a question, please feel free to e-mail me at [email protected], and I can ask on your behalf.

With that, Erez, Rick, thanks for doing this. I definitely appreciate the opportunity to host you guys and looking more -- looking forward to hearing more about Dario.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot